We are live on ! Find out more
SEI Investments

SEI Investments Portfolio holdings

AUM $108B
1-Year Est. Return 26.14%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+26.14%
3 Year Est. Return
+80.41%
5 Year Est. Return
+95.44%
10 Year Est. Return
+382.16%
AUM
$45B
AUM Growth
+$170M
Cap. Flow
-$2.88B
Cap. Flow %
-6.41%
Top 10 Hldgs %
16.72%
Holding
2,757
New
109
Increased
859
Reduced
1,347
Closed
244

Sector Composition

Rank Sector Weight
1 Technology 15.76%
2 Healthcare 11.58%
3 Financials 10.07%
4 Consumer Discretionary 7.69%
5 Industrials 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSTA
2351
DELISTED
Vasta Platform
VSTA
$78.6K ﹤0.01%
19,643
ARC
2352
DELISTED
ARC Document Solutions, Inc.
ARC
$78.6K ﹤0.01%
26,811
-2,277
-8% -$6.03K
SLQT icon
2353
SelectQuote
SLQT
$132M
$78.5K ﹤0.01%
116,800
DOUG icon
2354
Douglas Elliman
DOUG
$154M
$75.8K ﹤0.01%
19,548
-54,899
-74% -$219K
ESPR
2355
DELISTED
Esperion Therapeutics
ESPR
$73.1K ﹤0.01%
11,737
-880
-7% -$6.29K
ARAY icon
2356
Accuray
ARAY
$32M
$69.3K ﹤0.01%
33,146
-3,892
-11% -$8.04K
CCCC icon
2357
C4 Therapeutics
CCCC
$385M
$66.3K ﹤0.01%
11,235
-366
-3% -$3.04K
SGMO
2358
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$65.2K ﹤0.01%
20,745
-98
-0.5% -$380
CGNT icon
2359
Cognyte Software
CGNT
$659M
$63.7K ﹤0.01%
20,477
-2,844
-12% -$8.35K
ALTO icon
2360
Alto Ingredients
ALTO
$369M
$63.4K ﹤0.01%
22,019
-34,285
-61% -$122K
OVID icon
2361
Ovid Therapeutics
OVID
$414M
$62.9K ﹤0.01%
33,832
OABI icon
2362
OmniAb
OABI
$287M
$61.1K ﹤0.01%
+16,976
New +$89.1K
TTI icon
2363
TETRA Technologies
TTI
$1.14B
$59.9K ﹤0.01%
17,302
+1,032
+6% +$4.01K
FSP
2364
Franklin Street Properties
FSP
$47.2M
$59.3K ﹤0.01%
+21,704
New +$60.1K
NGD
2365
DELISTED
New Gold Inc
NGD
$57.5K ﹤0.01%
58,724
-26,266
-31% -$26.4K
RBBN icon
2366
Ribbon Communications
RBBN
$377M
$57.5K ﹤0.01%
20,557
-1,666
-7% -$4.32K
TEAD
2367
Teads Holding Co
TEAD
$68.7M
$56.5K ﹤0.01%
15,600
+4,300
+38% +$16.8K
NKTR icon
2368
Nektar Therapeutics
NKTR
$2.39B
$52K ﹤0.01%
1,534
+333
+28% +$16.1K
AFMD
2369
DELISTED
Affimed
AFMD
$51.9K ﹤0.01%
+4,184
New +$73.4K
ATRA icon
2370
Atara Biotherapeutics
ATRA
$75.5M
$50.8K ﹤0.01%
619
-28
-4% -$2.92K
MAGN
2371
Magnera Corp
MAGN
$472M
$41.5K ﹤0.01%
+1,150
New +$47K
ORGO icon
2372
Organogenesis Holdings
ORGO
$305M
$40.7K ﹤0.01%
+15,137
New +$44.2K
QMCO icon
2373
Quantum Corp
QMCO
$419M
$40.6K ﹤0.01%
1,867
-441
-19% -$10.8K
AMRN
2374
Amarin Corp
AMRN
$298M
$33.3K ﹤0.01%
+1,377
New +$33.1K
AMRX icon
2375
Amneal Pharmaceuticals
AMRX
$5.85B
$33K ﹤0.01%
16,594
-642
-4% -$1.44K

Similar funds

SEI Investments's Q4 2022 Portfolio in Review

As of Q4 2022, SEI Investments held 2,757 positions worth $45B, up 0.38% from $44.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

SEI Investments withdrew a net $2.88B in Q4 2022, closing 244 positions and reducing 1,347 holdings. Its most notable exit was Abiomed Inc, an estimated $63.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, SEI Investments opened a new position in iShares Core MSCI International Developed Markets ETF worth $219M.

  • SEI Investments's largest Q4 2022 buy was iShares Core MSCI International Developed Markets ETF: 3,906,565 shares worth $219M.
  • SEI Investments added most to Vanguard Emerging Markets Government Bond ETF in Q4 2022, an estimated $222M increase.
  • SEI Investments's biggest Q4 2022 reduction was iShares JPMorgan USD Emerging Markets Bond ETF, cutting an estimated $223M.
  • SEI Investments fully exited Abiomed Inc in Q4 2022, selling an estimated $63.5M.
  • SEI Investments's ten largest holdings make up 17% of its $45B portfolio in Q4 2022.
  • SEI Investments opened 109 new positions and closed 244 in Q4 2022.
  • SEI Investments's portfolio value rose 0.38% quarter-over-quarter to $45B.

Based on SEI Investments's 13F filing for Q4 2022, filed 10 Feb 2023.